Site Search
Displaying results 391 - 400 of 573
Resource | Publications,
The Treatment 2015 framework leverages existing international and national guidelines to generate new ways of thinking about HIV testing and treatment. Rather than expecting people to adapt themselves to complicated service systems, Treatment 2015 calls for systems to be adapted to the needs and circumstances of the people who use them. Community-led initiatives are vital to expanding and sustaining access to life-saving treatment services.
As the evidence base continues to evolve and new challenges and opportunities emerge, new mechanisms for translating evidence into action will be needed. Efforts to scale up treatment will need to respond more swiftly to information on epidemiological trends and service coverage using a data-driven strategic approach that focuses programming on the populations and settings in which HIV is spreading most rapidly and the unmet need for HIV treatment is most acute.
Resource | Publications,
The primary purpose of undertaking this seven-country consultation meeting in April 2013 was to identify the national laws and policies which need review and/or reform, or other programme initiatives which will increase access to rights-respecting HIV services by eliminating real or perceived impediments to delivery of equitable health services to all individuals and communities.
It was intended that countries would develop a measurable and monitorable action plan for undertaking key legal and policy reforms at country level to bring national legislation and policies in line with international good practice relating to human rights and rights-based HIV responses which the United Nations and/or other partners can support in the lead up to the 2015 deadline for achieving global targets and commitments on HIV, including the MDGs, Declaration of Commitment (2006) and Political Declaration (2011), and as part of the ESCAP Framework for regional support to countries.
Resource | Publications,
This report is a guide for policymakers, treatment providers and advocates interested in learning more about laboratory-based and point-of-care viral load HIV diagnostic products, and point-of-care CD4 HIV diagnostic products.
The report includes: information on how routine viral load (VL) monitoring improves HIV treatment outcomes; information on why the use of VL monitoring is particularly important for confirming treatment failure and for ensuring prevention of mother-to-child transmission of HIV (PMTCT); decision guide for purchasers, and information on how to evaluate the use of point-of-care (POC) and lab-based technologies in different contexts; technical specifications and pricing information for 13 diagnostic tools.
Resource | Publications,
Unitaid produced a new strategy for 2013-2016. The strategy concentrates on 6 Strategic Objectives that focus on products needed to reduce the burden of the three diseases where that burden is highest, in the world’s poorest populations. To support implementation of the new strategy, Unitaid’s Board approved a new set of Key Performance Indicators (KPIs) that are aligned with the strategy and designed to measure results across the Strategic Objectives and over time. This report is the first to present results for the new KPIs and sets the benchmark against which subsequent years can be measured and achievements demonstrated.
Resource | Presentations,
7th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 3 July 2013 Kuala Lumpur, Malaysia
Resource | Publications,
This paper documents the recent developments, opportunities and challenges in intellectual property rights and access to affordable medicines in China. In particular, the paper finds that there have been impressive achievements in the national response to the HIV epidemic in China. Examples include the rapid expansion of government-supported antiretroviral (ARV) schemes and the development of a legal framework on intellectual property to address access to affordable pharmaceutical products in China.
Adoption of the National Intellectual Property Strategy by the State Council in June 2008, and the revisions to the Patent Law and the Implementing Regulations with strong focus on public health protection are among the most prominent legal and policy achievements over the recent years, founding an enabling environment for action.
Resource | Publications,
United Nations entities, civil society networks and development partners in Asia and the Pacific are joining to urge for a rapid increase of voluntary confidential community-based HIV testing and counseling for key populations at higher risk—including men who have sex with men, transgender people, sex workers and people who use drugs— in the region, to help ensure more people in need are able to access life-saving antiretroviral treatment.
Low levels of access to HIV testing and counselling for key populations at higher risk remains a serious cause for concern in Asia and the Pacific. Across the region, less than half of the key populations know their HIV status, which can lead to late diagnosis, late initiation to care and treatment services, and can result in unnecessarily high morbidity and mortality for people living with HIV. This also means the benefits of the prevention impact of antiretroviral treatment are not being fully maximized in the region.
Resource | Publications,
Middle-income countries (MICs) are facing a crisis of containing costs for treating people living with HIV. These countries carry a high burden of HIV, and transmission of the virus is often concentrated amongst key populations: people who inject drug (PWID), men who have sex with men (MSM), sex workers (SW), transgender (TG), prisoners and migrants.
This policy brief examines the challenges to affordable HIV treatment access in MICs amongst people living with HIV (PLHIV) and key populations.
Resource | Publications,
The UNITAID 2013-2016 Strategy includes the treatment of HIV/AIDS and co-infections as one of six strategic objectives. This scoping report focuses on issues, challenges and opportunities related to one of the most important HIV co-infections—Hepatitis C virus (HCV)—and represents UNITAID’s first effort to gather market intelligence on products for the diagnosis and treatment of HCV in individuals co-infected with HIV and HCV.
Though preliminary in nature, this scoping report gives an overview of the prevalence and impact of HCV and HIV co-infection, existing medicines and diagnostics as well as those in the pipeline, commodity access issues, and market shortcomings.
Resource | Publications,
This landscape report is part of an ongoing initiative within UNITAID to describe and monitor the landscape for HIV commodities. It provides a broad overview of key HIV prevention tools, describing market dynamics around such prevention technologies and the primary factors that affect commodity access in HIV-endemic countries. Specifically, the report describes and analyses the market and technology landscapes for (i) male circumcision devices, (ii) barrier methods, (iii) microbicides, (iv) antiretroviral-based methods and (v) commodities needed for harm reduction. The report also explores market-based interventions that could alleviate current market shortcomings to improve access, focusing on key emerging products and product areas that are rapidly evolving.